Immunovant, Inc. IMVT Q1 2026 earnings
Reported August 11, 2025 · Before market open
EPS estimate-$0.69
Next report
Aug 10, 2026 (In 4 weeks)EPS estimate-$0.66
Financials
Q1 2026Valuation & ratios
Versus estimates
Diluted EPS
Ask the moment Immunovant, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Immunovant, Inc. report Q1 2026 earnings?
- Immunovant, Inc. (IMVT) reported Q1 2026 earnings on August 11, 2025 before market open.
- What were Immunovant, Inc.'s Q1 2026 revenue and EPS?
- Immunovant, Inc. reported diluted EPS of $-0.60 for Q1 2026.
- Did Immunovant, Inc. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.69 by $0.09.
- How did Immunovant, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 0.0% from $-0.60.
- Where can I find Immunovant, Inc.'s Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001764013-25-000129) directly on SEC EDGAR. The filing index links above go to sec.gov.